Overview

• The Health Ministry expanded SUS coverage to offer routine mammography from age 40, including for women without symptoms.
• The government purchased 34,400 vials of trastuzumabe entansina for HER2‑positive cases for R$159.3 million after negotiating roughly a 50% price cut.
• An initial shipment of 11,978 units arrived at Guarulhos two weeks ago, with four lots scheduled through June 2026 and treatment projected for 1,144 patients in 2025.
• Authorities say the new therapy could reduce mortality by up to 50% in eligible patients, complementing investments in outreach and diagnosis.
• Twenty‑eight mobile units began operating this month to deliver 130,000 procedures for 42,500 patients in 22 states, with a plan to reach 150 units by 2026 as experts cite low screening coverage and a roughly 95% cure rate when detected early.